WHO & Regional Offices [to 06 Nov 2021]

WHO & Regional Offices [to 06 Nov 2021]
https://www.who.int/
Selected News, Statements
5 November 2021
Note for Media
FAO/WHO Joint Media Advisory: Codex Alimentarius Commission

4 November 2021
Departmental news
Director-General’s Global Health Leaders Award for Annette Kennedy, President of the International Council of Nurses

4 November 2021
Medical product alert
Medical Product Alert N°7/2021: Falsified COVID-19 Vaccine AstraZeneca
[See COVID above for detail]

4 November 2021
Medical product alert
Medical Product Alert N°6/2021: Falsified Pfizer-BioNTech COVID-19 Vaccine
[See COVID above for detail]

3 November 2021
Departmental news
Innovative diagnostics are key to achieving the 2030 targets for neglected tropical diseases

3 November 2021
News release
WHO issues emergency use listing for eighth COVID-19 vaccine
[See COVID above for detail]

3 November 2021
Departmental news
Interim guidance for use of the Bharat BBV152 Covaxin vaccine published

3 November 2021
Departmental news
WHO issues a new compendium of data and evidence-related tools for use in TB planning and programming

2 November 2021
Departmental news
Urgent need for vaccine to prevent deadly Group B streptococcus

::::::

Weekly Epidemiological Record, Vol. 96, No. 44, pp. 537–548 5 November 2021
:: El Salvador and China certified as malaria-free by WHO
:: Routine vaccination coverage – worldwide, 2020

::::::

 

WHO Regional Offices
Selected Press Releases, Announcements
WHO African Region AFRO
:: WHO emergency teams learning and supporting in Malawi 03 November 2021

WHO Region of the Americas PAHO
No new digest content identified

WHO South-East Asia Region SEARO
No new digest content identified

WHO European Region EURO
:: Europe and central Asia again at the epicentre of the pandemic 04-11-2021
:: No polio detected in Tajikistan since third round of supplemental immunization 01-11-2021

WHO Eastern Mediterranean Region EMRO
No new digest content identified

WHO Western Pacific Region
:: East Asia and Pacific countries commit to ending violence against children during COVID-19 and beyond 5 November 2021

::::::

New WHO Publications [Selected]
https://www.who.int/publications/i
Selected Titles
4 November 2021
Key planning recommendations for mass gatherings in the context of COVID-19
Overview
The purpose of this document is to provide guidance to host governments, health authorities and national or international event organizers on taking decisions related to holding mass gatherings in the context of the COVID-19 pandemic, and on decreasing the risks of SARS-CoV-2 transmission and strain on health systems associated with such events, through dedicated precautionary measures.
The information contained in this document includes considerations for the practical planning and management of mass gatherings, as well as technical recommendations derived from WHO guidance on specific aspects; these have been consolidated and tailored to facilitate their application to the context of mass gatherings.
This is the fourth version (third update) of this interim document. First published on 14 February 2020 as Key planning recommendations for mass gatherings in the context of the current COVID-19 outbreak , it has been updated on 19 March 2020 and on 29 May 2020 prior to this version. The current version of all WHO information products and publications is authoritative.

3 November 2021
Interim recommendations for use of the Bharat Biotech BBV152 COVAXIN® vaccine against COVID-19

3 November 2021
Annexes to the interim recommendations for use of the Bharat Biotech BBV152 COVAXIN® vaccine against…

3 November 2021
Compendium of data and evidence-related tools for use in TB planning and programming

3 November 2021
Background document on the Bharat Biotech BBV152 COVAXIN® (COVID-19) vaccine

3 November 2021
World Health Organization strategy for engaging religious leaders, faith-based organizations and faith communities in health emergencies

2 November 2021
Full Value of Vaccine Assessment: Group B Streptococcus Vaccine Executive Summary

2 November 2021
Group B Streptococcus Vaccine: full value vaccine assessment

2 November 2021
Full Value of Vaccine Assessment: Group B Streptococcus Vaccine – Policy and Implementation Issues

2 November 2021
Group B Streptococcus vaccine: full value of vaccine assessment. Financial analysis